TWA
FLGT icon

TCI Wealth Advisors’s Fulgent Genetics FLGT Stock Holding History

TCI Wealth Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24
Closed -$750 – 930
2023
Q1 		$750 Hold
24
– – ﹤0.01% 2152
2022
Q4 		$715 Sell
24
-125
-84% -$4.47K ﹤0.01% 2169
2022
Q3 		$6K Hold
149
– – ﹤0.01% 1336
2022
Q2 		$8K Hold
149
– – ﹤0.01% 1142
2022
Q1 		$9K Buy
149
+51
+52% +$3.36K ﹤0.01% 1150
2021
Q4 		$10K Buy
98
+6
+7% +$527 ﹤0.01% 1158
2021
Q3 		$8K Buy
92
+61
+197% +$5.54K ﹤0.01% 1248
2021
Q2 		$3K Buy
31
+12
+63% +$958 ﹤0.01% 1745
2021
Q1 		$2K Buy
+19
New +$1.96K ﹤0.01% 1743

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

TCI Wealth Advisors's FLGT Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Fulgent Genetics (FLGT) in Q2 2023, closing a stake of 24 shares — an estimated $750 sold.

TCI Wealth Advisors first reported a position in FLGT in Q1 2021 and held it in 9 quarters. The position peaked at $10K in Q4 2021. 214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Fulgent Genetics position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 24 Fulgent Genetics shares in Q2 2023, an estimated $750.
  • TCI Wealth Advisors first reported a position in Fulgent Genetics in Q1 2021 and held it in 9 quarters.
  • TCI Wealth Advisors's Fulgent Genetics position peaked at $10K in Q4 2021.
  • 214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.